ASCO Interview 2013: Matthias Holdhoff discusses his presentation on primary CNS lymphoma
Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Dr Jaishri Blakeley, Director, The Johns Hopkins Hospital Comprehensive Neurofibromatosis Center.
Dr Erin Dunbar, Assistant Professor and Co. Director, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Department of Neurosurgery, University of Florida.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
A review of the presentation by Jaume Capdevila, Barcelona Spain. Unfortunately Neuroendocrine tumours (NETs) are often advanced at the time of diagnosis and the 5 year survival ranges… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
Trend toward more cancers and more deaths among heart failure patients. Heart failure patients are surviving more often with the heart condition but they are increasingly more likely… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.